Gefticip is a type of drug called a tyrosine kinase inhibitor (TKI), also known as a cancer growth inhibitor. Kinases are proteins in the body that regulate how the cells grow and divide. Gefticip blocks the protein from sending signals to the cancer cells that make them grow and divide.
Gefticip is used to treat some people with non-small cell lung cancer (NSCLC). It only works for cancers that have an abnormal form of a protein called epidermal growth factor receptor (EGFR). Tests are done on the cancer cells from a lung biopsy or previous surgery to check the level of EGFR.
Gefticip 250 mg tablet
is an anti-cancer
medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
The dosage and drug form depends on the age, weight and medical condition of an individual. Take Gefitinib as prescribed by your doctor.
Swallow the tablet whole, but do not crush or chew the tablet. Take the drug with or without food.
If you miss a dose of Gefitinib, take it immediately once you remember. However, if it is almost time for your next dose, then skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed dose.
What are the drugs that interact with Gefitinib?
The drugs that interact with Gefitinib are:
This is not a comprehensive list of drug interactions. Consult your doctor to know more about other possible drug interactions.